Splicing modulation therapy in the treatment of genetic diseases

被引：34

作者：

Arechavala-Gomeza, Virginia ^{[1
]}

Khoo, Bernard ^{[2
]}

Aartsma-Rus, Annemieke ^{[3
]}

机构：

[1] BioCruces Hlth Res Inst, Neuromuscular Disorders Grp, Baracaldo, Bizkaia, Spain

[2] UCL, Div Med, Endocrinol, London, England

[3] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands

来源：

APPLICATION OF CLINICAL GENETICS | 2014年 / 7卷

关键词：

splicing; therapy; antisense oligonucleotides; cryptic splicing; alternative splicing;

D O I：

10.2147/TACG.S71506

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Antisense-mediated splicing modulation is a tool that can be exploited in several ways to provide a potential therapy for rare genetic diseases. This approach is currently being tested in clinical trials for Duchenne muscular dystrophy and spinal muscular atrophy. The present review outlines the versatility of the approach to correct cryptic splicing, modulate alternative splicing, restore the open reading frame, and induce protein knockdown, providing examples of each. Finally, we outline a possible path forward toward the clinical application of this approach for a wide variety of inherited rare diseases.

引用

页码：245 / 252

页数：8

共 65 条

[51] Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl-Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates [J].

Rigo, Frank ;

Chun, Seung J. ;

Norris, Daniel A. ;

Hung, Gene ;

Lee, Sam ;

Matson, John ;

Fey, Robert A. ;

Gaus, Hans ;

Hua, Yimin ;

Grundy, John S. ;

Krainer, Adrian R. ;

Henry, Scott P. ;

Bennett, C. Frank .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (01) :46-55

[52] Pick one, but be quick: 5′ splice sites and the problems of too many choices [J].

Roca, Xavier ;

Krainer, Adrian R. ;

Eperon, Ian C. .

GENES & DEVELOPMENT, 2013, 27 (02) :129-144

[53]

Saleh AF, 2012, METHODS MOL BIOL, V867, P365, DOI 10.1007/978-1-61779-767-5_23

[54] Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome [J].

Scaffidi, P ;

Misteli, T .

NATURE MEDICINE, 2005, 11 (04) :440-445

[55] Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs [J].

Soutschek, J ;

Akinc, A ;

Bramlage, B ;

Charisse, K ;

Constien, R ;

Donoghue, M ;

Elbashir, S ;

Geick, A ;

Hadwiger, P ;

Harborth, J ;

John, M ;

Kesavan, V ;

Lavine, G ;

Pandey, RK ;

Racie, T ;

Rajeev, KG ;

Röhl, I ;

Toudjarska, I ;

Wang, G ;

Wuschko, S ;

Bumcrot, D ;

Koteliansky, V ;

Limmer, S ;

Manoharan, M ;

Vornlocher, HP .

NATURE, 2004, 432 (7014) :173-178

[56] Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA [J].

Stoilov, P ;

Daoud, R ;

Nayler, O ;

Stamm, S .

HUMAN MOLECULAR GENETICS, 2004, 13 (05) :509-524

[57] RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice [J].

Svasti, Saovaros ;

Suwanmanee, Thipparat ;

Fucharoen, Suthat ;

Moulton, Hong M. ;

Nelson, Michelle H. ;

Maeda, Nobuyo ;

Smithies, Oliver ;

Kole, Ryszard .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (04) :1205-1210

[58] Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens [J].

Taylor, L. E. ;

Kaminoh, Y. J. ;

Rodesch, C. K. ;

Flanigan, K. M. .

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2012, 38 (06) :591-601

[59] Local dystrophin restoration with antisense oligonucleotide PRO051 [J].

van Deutekom, Judith C. ;

Janson, Anneke A. ;

Ginjaar, Ieke B. ;

Frankhuizen, Wendy S. ;

Aartsma-Rus, Annemieke ;

Bremmer-Bout, Mattie ;

den Dunnen, Johan T. ;

Koop, Klaas ;

van der Kooi, Anneke J. ;

Goemans, Nathalie M. ;

de Kimpe, Sjef J. ;

Ekhart, Peter F. ;

Venneker, Edna H. ;

Platenburg, Gerard J. ;

Verschuuren, Jan J. ;

van Ommen, Gert-Jan B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26) :2677-2686

[60]

van Roon-Mom WMC, 2012, METHODS MOL BIOL, V867, P79, DOI 10.1007/978-1-61779-767-5_6

← 1 2 3 4 5 6 7 →